Syntax Research’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.2K Hold
2025
Q1
$8.51K Hold
2024
Q4
$9.84K Hold
2024
Q3
$11.7K Hold
2024
Q2
$13.5K Hold
2024
Q1
$17K Hold
2023
Q4
$15.7K Hold
2023
Q3
$11.3K Buy